We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CBAV.MC

Price
49.80
Stock movement down
-1.60 (-3.11%)
Company name
Clinica Baviera
Exchange
(MC
,
Currency
EUR
)
Sector
Healthcare >
Diagnostics & Research
Market cap
797.40M
Ent value
884.20M
Price/Sales
2.72
Price/Book
8.19
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
19.70
Forward P/E
-
PEG
-
EPS growth
25.77%
1 year return
53.23%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2026-01-16

DIVIDENDS

CBAV.MC does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E19.70
Price to OCF11.04
Price to FCF17.14
Price to EBITDA11.44
EV to EBITDA12.68

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.72
Price to Book8.19
EV to Sales3.01

FINANCIALS

Per share

Loading...
Per share data
Current share count16.01M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash43.85M
Net receivables8.94M
Total current assets52.79M
Goodwill0.00
Intangible assets38.83M
Property, plant and equipment131.20M
Total assets228.01M
Accounts payable21.65M
Short/Current long term debt66.61M
Total current liabilities34.39M
Total liabilities130.65M
Shareholder's equity97.36M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open49.90
Daily high51.60
Daily low49.60
Daily Volume1K
All-time high51.80
1y analyst estimate24.30
Beta0.74
EPS (TTM)-
Dividend per share0.00
Ex-div date15 Jul 2025
Next earnings date-

Downside potential

Loading...
Downside potential data
CBAV.MCS&P500
Current price drop from All-time high-3.86%-0.50%
Highest price drop-21.39%-19.00%
Date of highest drop27 Dec 20248 Apr 2025
Avg drop from high-7.37%-2.50%
Avg time to new high10 days6 days
Max time to new high139 days89 days
COMPANY DETAILS
CBAV.MC (Clinica Baviera) company logo
Marketcap
797.40M
Marketcap category
Small-cap
Description
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is headquartered in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.
Employees
1847
Investor relations
-
CEO
Country
Spain
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As the pan-European STOXX Europe 600 Index edges closer to record highs, buoyed by optimism about future earnings and economic prospects, investors are increasingly turning their attention to lesser-k...
January 1, 2026
As the European market continues to show resilience with the STOXX Europe 600 Index rising by 2.35%, investors are keeping a close eye on economic indicators, such as subdued inflation rates that sugg...
December 3, 2025
As European markets experience a mix of relief from the reopening of the U.S. federal government and tempered enthusiasm due to cooling sentiment on artificial intelligence, investors are keenly obser...
November 18, 2025
As European markets navigate a mixed landscape—buoyed by dovish signals from the U.S. Federal Reserve and tempered by regional economic challenges such as the contraction in eurozone industrial output...
October 20, 2025
As European markets experience a pullback, with the STOXX Europe 600 Index retreating from record highs amid political turmoil and trade tensions, investors are increasingly on the lookout for resilie...
October 17, 2025
As European markets grapple with the impact of a disappointing trade framework between the U.S. and EU, reflected in a 2.57% drop in the STOXX Europe 600 Index, investors are keenly observing economic...
August 4, 2025
As European markets navigate the complexities of trade deals and economic stagnation, investors are increasingly looking towards dividend stocks as a potential source of stability and income. In such ...
August 4, 2025
As the European market experiences a modest upswing, buoyed by easing geopolitical tensions and potential economic stimulus in Germany, investors are increasingly eyeing small-cap stocks for their gro...
July 3, 2025
As European markets experience a positive upswing, buoyed by easing trade tensions and potential economic stimulus in Germany, investors are increasingly looking towards dividend stocks as a reliable ...
July 2, 2025
The European market has recently shown resilience, with the STOXX Europe 600 Index rising by 0.65%, buoyed by easing trade tensions and slowing inflation in key economies like Germany and Italy. As in...
June 4, 2025
Next page